Health Commissioner: We Are at a CRITICAL POINT

Community NewsNews
249

Translate to Spanish or other 102 languages!

Image for illustration purposes.

Mega Doctor News

- Advertisement -

Legislators had a call with Texas Department of State Health Services Commissioner John Hellerstedt to discuss COVID-19. He made it very clear we are again at a CRITICAL point. We are seeing a surge of COVID cases and hospitalizations across the nation, and Texas is NO EXCEPTION! 

The Delta variant is more transmissible, more deadly, and individuals with underlying vulnerabilities are at higher risk of severe infection and death. 95-99% of those currently hospitalized are unvaccinated. The slides below prove that the vaccine works.

We cannot eliminate this terrible and deadly disease without more individuals in our state getting the vaccine. If you have not gotten the vaccine, please get one as soon as possible. The vaccine not only protects you, it protects all of us.

- Advertisement -

Help us put COVID behind us. Find a COVID-19 vaccine near you by clicking on this link, www.vaccines.gov.

Increases in COVID-19 Hospitalizations
Increases in Pediatric Hospitalizations
 
Vaccination Decreases Hospitalizations
Vaccination Decreases Mortality
Conclusions
Vaccination Rates in SD 20

All images courtesy of Texas Health and Human Services.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
University of Houston College of Medicine to Open Direct Primary Care Clinic for the Uninsured
Next article
Neurosurgeon Jacinto I. Mañon, M.D., F.A.A.N.S, joins DHR Health Neuroscience Institute

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -